Illumina Investigator-Sponsored Oncology Research Support is available to qualified investigators and institutions proposing clinical studies that evaluate Illumina genomics products or technology. Oncology is one of several eligible clinical areas.
Investigators can submit a proposal without waiting for a specific call. For investigator-sponsored studies, the external researcher or institution serves as the study sponsor and is responsible for study conduct and regulatory obligations.
Eligibility Criteria
- Qualified investigators and research institutions may submit proposals.
- Oncology studies must involve an Illumina research-use-only or in vitro diagnostic product or technology.
- Proposals must align with Illumina’s clinical research priorities and explain the scientific rationale for the study.
- The external sponsor must be able to oversee the study and meet applicable legal and regulatory requirements.
- Nonclinical animal studies are outside the programme’s scope.
- Requested expenses must relate directly to conducting the study.
Funding Details
- Support: Financial funding, in-kind products or other support, or a combination, subject to local requirements.
- Award amount and duration: No standard amount or project term is published.
- Agreement: Approved studies require a signed agreement before support can begin.
How to Apply
- Use the Investigator Sponsored Research Proposal Template for an independent study. Use the Collaborative Research Proposal
- Template if requesting Illumina’s involvement in study design or execution.
- Use the Research Grants Proposal Template if you have secured or are seeking government or nonprofit foundation funding for the study.
- Email the completed proposal to iResearch@illumina.com.